secwatch.observer — SEC 8-K summary
======================================

Issuer:     BOSTON SCIENTIFIC CORP (BSX)
CIK:        0000885725
Form:       8-K
Filed at:   2023-06-27T23:59:59+00:00
Accession:  0000885725-23-000038
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Boston Scientific elects Jessica L. Mega and Susan E. Morano to board of directors
--------------------------------------------------------------------------------

- Dr. Mega is co-founder of Verily Life Sciences (Alphabet) and former chief medical officer; cardiologist at Brigham & Women's.
- Ms. Morano was VP of Business Development and Strategic Operations at Johnson & Johnson MedTech until Feb 2023.
- Board expanded from 10 to 11; appointments effective June 27, 2023, with prorated cash retainer ~$97,715 and equity award ~$174,188.
- Dr. Mega joins Compensation and Risk Committees; Ms. Morano joins Audit and Nominating & Governance Committees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885725/000088572523000038/0000885725-23-000038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885725/000088572523000038/bsx-20230627.htm
  HTML page:      https://secwatch.observer/filing/0000885725-23-000038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer